Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST000339)

(Analysis AN000550)

Metabolite	Structure	F1	F2
TG (56:2)	ME118254	0.67	1.33
TG (48:1)	ME118235	0.68	1.32
PC (p-34:1) or PC (o-34:2)	ME118200	0.69	1.31
SM (d34:2)	ME118221	0.69	1.31
TG (50:1)	ME118239	0.73	1.27
PC (36:2)	ME118180	0.70	1.30
PC (40:6)	ME118191	0.71	1.29
Cholesterol	ME118157	0.71	1.29
LPC (18:1)	ME118164	0.71	1.29
TG (54:6)	ME118252	0.61	1.39
TG (48:2)	ME118236	0.53	1.28
TG (56:4)	ME118255	0.58	1.32
TG (54:1)	ME118248	0.62	1.75
PC (38:2)	ME118184	0.54	1.46
TG (14:0/14:0/14:0)	ME118232	0.54	1.46
TG (52:3)	ME118245	0.48	1.52
TG (54:2)	ME118249	0.50	1.50
PC (36:3)	ME118181	0.51	1.49
TG (52:4)	ME118247	0.51	1.49
LPC (16:0)	ME118162	0.40	1.60
PC (34:2)	ME118175	0.41	1.59
TG (50:2)	ME118240	0.33	1.67
LPC (18:0)	ME118163	0.36	1.64
PC (38:3)	ME118185	0.37	1.63
SM (d43:2)	ME118231	1.10	0.39
PC (p-42:3) or PC (o-42:4)	ME118210	1.00	NA
PC (30:1)	ME118167	1.00	NA
PC (28:0)	ME118165	1.00	NA
CE (22:6)	ME118152	1.00	NA
CE (18:1)	ME118150	1.00	NA
CE (20:4)	ME118151	1.00	NA
PC (o-34:0)	ME118198	1.53	0.47
PE (p-40:5) or PE (o-40:6)	ME118217	1.53	0.47
PC (p-40:3) or PC (o-40:4)	ME118207	1.48	0.52
TG (52:1)	ME118243	1.51	0.49
PC (p-42:5) or PC (o-42:6)	ME118212	1.49	0.51
GlcCer (d42:1)	ME118160	1.50	0.50
PC (34:0)	ME118173	1.50	0.50
Ceramide (d18:1/23:0)	ME118153	1.51	0.58
PC (38:4)	ME118186	1.46	0.54
PC (p-40:4) or PC (o-40:5)	ME118208	1.46	0.54
PC (32:1)	ME118170	1.41	0.59
PC (p-38:5) or PC (o-38:6)	ME118206	1.43	0.57
PC (p-40:6) or PC (o-40:7)	ME118209	1.44	0.56
TG (56:5)	ME118256	1.40	0.66
PC (p-42:4) or PC (o-42:5)	ME118211	1.36	0.64
PC (42:5)	ME118194	1.36	0.64
PC (p-38:4) or PC (o-38:5)	ME118205	1.36	0.64
PC (p-36:3) or PC (o-36:4)	ME118202	1.37	0.63
TG (54:3)	ME118250	1.37	0.63
PE (p-38:5) or PE (o-38:6)	ME118216	1.34	0.66
PC (p-34:0) or PC (o-34:1)	ME118199	1.33	0.67
TG (50:0)	ME118238	1.33	0.67
SM (d39:1)	ME118224	1.32	0.52
TG (58:6)	ME118261	1.37	0.56
TG (60:2)	ME118263	1.50	0.40
Gal-Gal-Cer(d18:1/16:0) or Lactosylceramide(d18:1/16:0)	ME118158	1.56	0.44
TG (58:1)	ME118258	1.57	0.43
PC (35:1)	ME118178	1.64	0.36
SM (d42:1)	ME118228	1.62	0.38
SM (d41:2)	ME118227	1.63	0.37
PC (p-38:3) or PC (o-38:4)	ME118204	1.63	0.37
SM (d36:1)	ME118222	1.63	0.37
PC (30:0)	ME118166	1.61	0.39
PC (33:0)	ME118171	1.60	0.40
PC (36:5)	ME118183	1.59	0.41
PC (o-32:0)	ME118197	1.59	0.41
SM (d40:1)	ME118225	1.80	0.20
Ceramide (d40:1)	ME118154	1.76	0.24
PC (33:1)	ME118172	1.78	0.22
GlcCer (d40:1)	ME118159	1.68	0.32
Ceramide (d42:1)	ME118155	1.67	0.33
SM (d32:1)	ME118218	1.67	0.33
PC (31:0)	ME118168	1.73	0.27
PC (34:4)	ME118177	1.72	0.28
SM (d38:1)	ME118223	1.71	0.29
PC (40:7)	ME118192	1.12	0.88
SM (d33:1)	ME118219	1.12	0.88
PC (34:3)	ME118176	1.14	0.86
PC (p-36:1) or PC (o-36:2)	ME118201	1.15	0.85
PC (p-36:4) or PC (o-36:5)	ME118203	1.15	0.85
SM (d41:1)	ME118226	1.27	0.73
TG (58:2)	ME118259	1.28	0.72
PC (34:1)	ME118174	1.20	0.80
SM (d42:2)	ME118229	1.20	0.80
PC (40:5)	ME118190	1.19	0.81
PC (42:7)	ME118196	1.19	0.81
PC (40:8)	ME118193	1.17	0.83
TG (58:8)	ME118262	1.19	0.84
TG (52:0)	ME118242	1.22	0.73
TG (52:2)	ME118244	1.21	0.79
Ceramide (d42:2)	ME118156	1.23	0.77
PC (38:5)	ME118187	1.23	0.77
PC (36:1)	ME118179	1.22	0.78
SM (d42:3)	ME118230	1.22	0.78
GlcCer (d42:2)	ME118161	0.86	1.14
PC (36:4)	ME118182	0.88	1.12
PC (38:6)	ME118188	0.84	1.16
TG (46:0)	ME118233	0.82	1.18
TG (54:4)	ME118251	0.81	1.19
PC (42:6)	ME118195	1.08	0.92
SM (d34:1)	ME118220	1.04	0.96
TG (56:6)	ME118257	1.04	0.96
PE (p-36:4) or PE (o-36:5)	ME118214	1.05	0.95
PC (32:0)	ME118169	1.06	0.94
TG (58:4)	ME118260	1.06	0.94
PE (38:6)	ME118213	0.92	1.08
TG (56:1)	ME118253	0.94	1.06
PC (40:4)	ME118189	0.93	1.07
TG (48:0)	ME118234	0.93	1.07
PE (p-38:4) or PE (o-38:5)	ME118215	1.01	0.99
TG (49:0)	ME118237	0.99	1.03
TG (51:1)	ME118241	0.99	1.03

Factors:

F1	Treatment:Bone marrow macrophage
F2	Treatment:Resident macrophage

Data matrix